NCT02061800 2024-06-04CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantColumbia UniversityPhase 1/2 Active not recruiting14 enrolled
NCT00301834 2017-09-28Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic DisordersUniversity of California, San FranciscoPhase 2 Completed35 enrolled 11 charts